How Virtual Reality Is Closing the Skills Gap Across Education, Care, and Pharmaceutical Manufacturing
As the UK marks International Day of Education (24 January), one challenge is becoming increasingly clear across education, healthcare, and life sciences: the people who will design, manufacture, and deliver tomorrow’s medicines are in short supply today.
Advanced medicines manufacturing—particularly in cell and gene therapies, biologics, and regenerative medicine—is expanding rapidly. Yet the pipeline of skilled workers has failed to keep pace. Traditional training routes are struggling with cost, access, and scalability, while younger learners often have little exposure to what modern medicine manufacturing actually looks like.
A pioneering UK government-funded initiative, Resilience, is addressing this problem by rethinking how people learn—using virtual reality (VR) to train the next generation of medicine makers before they ever set foot in a real laboratory.
At the centre of the programme is Professor Ivan Wall, Professor of Regenerative Medicine at the University of Birmingham and co-director of the Resilience scheme.
A £4.3 Million Answer to a National Skills Challenge
Resilience is a two-year, £4.3 million programme, supported by UK government funding, designed to tackle a critical bottleneck in advanced medicines manufacturing: training capacity.
Modern pharmaceutical and regenerative medicine facilities are highly specialised environments. Cleanrooms, bioreactors, and tightly controlled processes mean that training new staff is expensive, time-consuming, and disruptive to live production.
VR offers a compelling alternative. Using immersive simulations, Resilience has recreated one of the UK’s most advanced medicines manufacturing laboratories in virtual form—allowing learners to experience authentic workflows without risk, waste, or restriction.
This approach delivers benefits that resonate across multiple sectors.
Implications for the Care Sector
The care sector—including healthcare assistants, clinical support workers, and allied health professionals—faces its own skills and confidence challenges.
Much early training in healthcare is not about technical mastery but about orientation, familiarity, and confidence. New staff must learn environments, processes, and safety protocols before they can focus fully on patient care.
VR excels in precisely these areas. Learners can rehearse procedures, navigate complex environments, and understand workflows repeatedly—without fear of making mistakes that could affect patients.
For care providers, this means:
- Faster onboarding
- Reduced pressure on experienced staff
- More confident, better-prepared workers
- Improved patient safety
As Professor Wall notes,
much of core training is about “knowing where you are, what happens next, and how your role fits into a larger system.” VR provides this understanding efficiently and consistently.
A Game-Changer for Medical & Pharmaceutical Manufacturing
In the medical and pharmaceutical sector, the benefits are even more pronounced.
Live laboratory space is one of the most expensive resources in the life sciences. Using it to train new staff often means slowing or stopping production. VR removes this trade-off entirely.
Trainees can repeat tasks dozens or even hundreds of times without wasting costly chemicals, reagents, or materials. Errors become learning opportunities rather than financial losses.
Crucially, VR also supports regulatory compliance and consistency. Standardised training environments ensure that procedures are taught identically across sites—an increasingly important factor in regulated industries.
As the UK seeks to strengthen its position as a global leader in advanced medicines manufacturing, scalable training solutions like VR will be essential.
Professor Ivan Wall: From Regenerative Medicine to Workforce Innovation
Professor Wall’s career bridges cutting-edge science and practical workforce development.
After completing a PhD in cell and molecular biology, researching wound healing, his work expanded into biomaterials, dental regeneration, and stem cell biology. In 2018, he became Professor at Aston University, where he led doctoral training and skills initiatives.
Since joining the University of Birmingham in 2022, his ambition has been clear: to help make Birmingham a hub for manufacturing cell and gene therapies, ensuring that patients can benefit locally from world-leading science.
Resilience is a key part of that vision—ensuring the workforce is ready before demand outstrips supply.
A Blueprint for the Future of Education and Care
What Resilience ultimately demonstrates is that education no longer has to be constrained by physical space, cost, or risk.
VR does not replace hands-on experience—it prepares learners for it. By the time individuals enter real laboratories, care settings, or manufacturing facilities, they do so with confidence, familiarity, and a clear understanding of processes.
For education providers, care organisations, and pharmaceutical manufacturers alike, the message is the same: immersive learning is no longer experimental—it is essential infrastructure for the future.
As International Day of Education reminds us, how we educate today determines what we can build tomorrow. With initiatives like Resilience, the UK is not only training future medicine makers—it is reimagining education itself.
